225 related articles for article (PubMed ID: 16641457)
41. In vitro activity and durability of a combination of an antibiofilm and an antibiotic against vascular catheter colonization.
Mansouri MD; Hull RA; Stager CE; Cadle RM; Darouiche RO
Antimicrob Agents Chemother; 2013 Jan; 57(1):621-5. PubMed ID: 23114776
[TBL] [Abstract][Full Text] [Related]
42. The bactericidal and antibiofilm effects of a lysine-substituted hybrid peptide, CM-10K14K, on biofilm-forming Staphylococcus epidermidis.
Klubthawee N; Wongchai M; Aunpad R
Sci Rep; 2023 Dec; 13(1):22262. PubMed ID: 38097636
[TBL] [Abstract][Full Text] [Related]
43. The Natural History and Composition of Urinary Catheter Biofilms: Early Uropathogen Colonization with Intraluminal and Distal Predominance.
Werneburg GT; Nguyen A; Henderson NS; Rackley RR; Shoskes DA; Le Sueur AL; Corcoran AT; Katz AE; Kim J; Rohan AJ; Thanassi DG
J Urol; 2020 Feb; 203(2):357-364. PubMed ID: 31430245
[TBL] [Abstract][Full Text] [Related]
44. Bacterial biofilms in patients with indwelling urinary catheters.
Stickler DJ
Nat Clin Pract Urol; 2008 Nov; 5(11):598-608. PubMed ID: 18852707
[TBL] [Abstract][Full Text] [Related]
45. Prevalence and antimicrobial susceptibility of bacterial pathogens isolated from urine specimens received in rizgary hospital - Erbil.
Al-Naqshbandi AA; Chawsheen MA; Abdulqader HH
J Infect Public Health; 2019; 12(3):330-336. PubMed ID: 30522892
[TBL] [Abstract][Full Text] [Related]
46. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). II. Background of patients].
Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F
Jpn J Antibiot; 1996 May; 49(5):494-508. PubMed ID: 8752863
[TBL] [Abstract][Full Text] [Related]
47. Antibiotic Lock Therapy in the Era of Gram-Negative Resistance.
Soman R; Gupta N; Suthar M; Kothari J; Almeida A; Shetty A; Rodrigues C
J Assoc Physicians India; 2016 Feb; 64(2):32-37. PubMed ID: 27730778
[TBL] [Abstract][Full Text] [Related]
48. Antimicrobial susceptibility pattern of bacteria isolated from patients with urinary tract infection.
Khan IU; Mirza IA; Ikram A; Afzal A; Ali S; Hussain A; Fayyaz M; Ghafoor T
J Coll Physicians Surg Pak; 2014 Nov; 24(11):840-4. PubMed ID: 25404444
[TBL] [Abstract][Full Text] [Related]
49. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin.
Raad I; Darouiche R; Hachem R; Mansouri M; Bodey GP
J Infect Dis; 1996 Feb; 173(2):418-24. PubMed ID: 8568304
[TBL] [Abstract][Full Text] [Related]
50. Activity of some antiseptics against urinary tract pathogens growing as biofilms on silicone surfaces.
Stickler D; Dolman J; Rolfe S; Chawla J
Eur J Clin Microbiol Infect Dis; 1991 May; 10(5):410-5. PubMed ID: 1908381
[TBL] [Abstract][Full Text] [Related]
51. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
Lee MY; Ko KS; Song JH; Peck KR
J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
[TBL] [Abstract][Full Text] [Related]
52. Antifungal activity of a β-peptide in synthetic urine media: Toward materials-based approaches to reducing catheter-associated urinary tract fungal infections.
Raman N; Lee MR; Rodríguez López AL; Palecek SP; Lynn DM
Acta Biomater; 2016 Oct; 43():240-250. PubMed ID: 27422198
[TBL] [Abstract][Full Text] [Related]
53. Restriction of in vivo infection by antifouling coating on urinary catheter with controllable and sustained silver release: a proof of concept study.
Mandakhalikar KD; Wang R; Rahmat JN; Chiong E; Neoh KG; Tambyah PA
BMC Infect Dis; 2018 Aug; 18(1):370. PubMed ID: 30081836
[TBL] [Abstract][Full Text] [Related]
54. Investigating the effect of biosynthesized silver nanoparticles as antibiofilm on bacterial clinical isolates.
Neihaya HZ; Zaman HH
Microb Pathog; 2018 Mar; 116():200-208. PubMed ID: 29414608
[TBL] [Abstract][Full Text] [Related]
55. Antibiofilm effect of Nocardiopsis sp. GRG 1 (KT235640) compound against biofilm forming Gram negative bacteria on UTIs.
Rajivgandhi G; Vijayan R; Maruthupandy M; Vaseeharan B; Manoharan N
Microb Pathog; 2018 May; 118():190-198. PubMed ID: 29524549
[TBL] [Abstract][Full Text] [Related]
56. In vitro activity of fosfomycin tromethamine against extended spectrum beta-lactamase producing urinary tract bacteria.
Khan IU; Mirza IA; Ikram A; Ali S; Hussain A; Ghafoor T
J Coll Physicians Surg Pak; 2014 Dec; 24(12):914-7. PubMed ID: 25523727
[TBL] [Abstract][Full Text] [Related]
57. Chlorpromazine-impregnated catheters as a potential strategy to control biofilm-associated urinary tract infections.
Sidrim JJ; Amando BR; Gomes FI; do Amaral MS; de Sousa PC; Ocadaque CJ; Brilhante RS; A Cordeiro R; Rocha MF; Scm Castelo-Branco D
Future Microbiol; 2019 Aug; 14():1023-1034. PubMed ID: 31469013
[No Abstract] [Full Text] [Related]
58. Micro-organisms attached to the lumens and balloons of indwelling urinary catheters and correlation with symptoms, antibiotic use and catheter specimen of urine results.
Belfield K; Kalith S; Aimar K; Parkinson R; Bayston R
J Med Microbiol; 2019 Apr; 68(4):549-554. PubMed ID: 30806614
[TBL] [Abstract][Full Text] [Related]
59. Escherichia coli N-Acetylglucosamine-1-Phosphate-Uridyltransferase/Glucosamine-1-Phosphate-Acetyltransferase (GlmU) Inhibitory Activity of Terreic Acid Isolated from Aspergillus terreus.
Sharma R; Lambu MR; Jamwal U; Rani C; Chib R; Wazir P; Mukherjee D; Chaubey A; Khan IA
J Biomol Screen; 2016 Apr; 21(4):342-53. PubMed ID: 26762501
[TBL] [Abstract][Full Text] [Related]
60. Antimicrobial and antibiofilm efficacy of triclosan and DispersinB combination.
Darouiche RO; Mansouri MD; Gawande PV; Madhyastha S
J Antimicrob Chemother; 2009 Jul; 64(1):88-93. PubMed ID: 19447791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
